Bone mineral density in patients with rheumatoid arthritis treated with infliximab

av Vis, M, Voskuyl, A, Wolbink, G, Dijkmans, B, Lems, W, t for
Publicerad 2005

Adverse events in patients with rheumatoid arthritis treated with infliximab in daily clinical practice

av Neven, N, Vis, M, Voskuyl, A, Wolbink, G, Nurmohamed, M, Dijkmans, B, Lems, W
Publicerad 2005

Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis

av Wolbink, G, Voskuyl, A, Lems, W, de Groot, E, Nurmohamed, M, Tak, P, Dijkmans, B, Aarden, L
Publicerad 2005

High levels of human anti‐human antibodies to adalimumab in a patient not responding to adalimumab treatment

av Bartelds, G M, Wolbink, G J, Stapel, S, Aarden, L, Lems, W F, Dijkmans, B A C, Nurmohamed, M T
Publicerad 2006

Inhibition of human complement by beta-glycyrrhetinic acid.

av Kroes, B H, Beukelman, C J, van den Berg, A J, Wolbink, G J, van Dijk, H, Labadie, R P
Publicerad 1997

Changes in the serum concentration and the glycosylation of human alpha 1-acid glycoprotein and alpha 1-protease inhibitor in severely burned persons: relation to interleukin-6 lev...

av Pos, O, van der Stelt, M E, Wolbink, G J, Nijsten, M W, van der Tempel, G L, van Dijk, W
Publicerad 1990

Therapeutic drug monitoring of anti-TNF drugs: an overview of applicability in daily clinical practice in the era of treatment with biologics in juvenile idiopathic arthritis (JIA)

av Nassar-Sheikh Rashid, A., Schonenberg-Meinema, D., Bergkamp, S. C., Bakhlakh, S., de Vries, A., Rispens, T., Kuijpers, T. W., Wolbink, G., van den Berg, J. M.
I publikationen Pediatr Rheumatol Online J (2021)

Inefficacy of infliximab in ankylosing spondylitis is correlated with antibody formation

av de Vries, M K, Wolbink, G J, Stapel, S O, de Groot, E R, Dijkmans, B A C, Aarden, L A, van der Horst‐Bruinsma, I E
Publicerad 2007

Imaging and serum analysis of immune complex formation of radiolabelled infliximab and anti‐infliximab in responders and non‐responders to therapy for rheumatoid arthritis

av van der Laken, C J, Voskuyl, A E, Roos, J C, van Walsum, M Stigter, de Groot, E R, Wolbink, G, Dijkmans, B A C, Aarden, L A
Publicerad 2007

Adherence to etanercept therapy in rheumatoid arthritis patients during 3 years of follow-up

av Vogelzang, E. H., Hebing, R. C. F., Nurmohamed, M. T., van Kuijk, A. W. R., Kruijff, J. W. F., l’Ami, M. J., Krieckaert, C. L. M., Wolbink, G.
I publikationen PLoS One (2018)

A prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on synovial tiss...

av van Kuijk, A W R, Gerlag, D M, Vos, K, Wolbink, G, de Groot, M, de Rie, M A, Zwinderman, A H, Dijkmans, B A C, Tak, P P
Publicerad 2008

The activation of polymorphonuclear neutrophils and the complement system during immunotherapy with recombinant interleukin-2.

av Baars, J. W., Hack, C. E., Wagstaff, J., Eerenberg-Belmer, A. J., Wolbink, G. J., Thijs, L. G., Strack van Schijndel, R. J., van der Vall, H. L., Pinedo, H. M.
Publicerad 1992

The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor α expression in the synovium

av Wijbrandts, C A, Dijkgraaf, M G W, Kraan, M C, Vinkenoog, M, Smeets, T J, Dinant, H, Vos, K, Lems, W F, Wolbink, G J, Sijpkens, D, Dijkmans, B A C, Tak, P P
Publicerad 2008

Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis

av Peters, M J L, Vis, M, van Halm, V P, Wolbink, G J, Voskuyl, A E, Lems, W F, Dijkmans, B A C, Twisk, J W R, de Koning, M H M T, van de Stadt, R J, Nurmohamed, M T
Publicerad 2007